GLP-1 receptor agonists and delayed gastric emptying: Another opportunity to use gastric ultrasound prior to the induction of general anesthesia Myron Yaster MD and Suryakumar Narayanasamy, MBBS, MD In yesterdays PAAD here, we reviewed the physiology of Glucagon-like peptide-1 (GLP-1) receptor agonist drugs which have transformed the management of type 2 diabetes and obesity
Injection into areas with less subcutaneous fat or closer proximity to nerve endings may also increase pain perception
1 Important Safety Information Eligibility Restrictions & Offer Terms for Your Patients: Sanofi Insulins Co-pay Savings Program: This savings program is not insurance
The American Diabetes Association (ADA) guidelines recommend GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes and atherosclerotic cardiovascular disease, while SGLT2 inhibitors are preferred for heart failure and chronic kidney disease
Professor Susan Jebb, joint senior author, adds: 'Obesity is a chronic, relapsing condition, not a short-term problem with a quick fix
Benefits of GLP-1 Agonists Many weight loss solutions fail because they dont address the underlying biological factors that contribute to weight gain